Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials
نویسندگان
چکیده
Qian Shi1,∗, Lindsay A. Renfro, Brian M. Bot, Tomasz Burzykowski, Marc Buyse and Daniel J. Sargent Department of Health Science Research , Mayo Clinic, Rochester, Minnesota, U.S.A. Department of Statistical Science, Baylor University, Waco, Texas, U.S.A Center for Statistics, Hasselt University, Diepenbeek, Belgium International Drug Development Institute, Hasselt University, Diepenbeek, Belgium *email: [email protected]
منابع مشابه
Bayesian adjusted R2 for the meta-analytic evaluation of surrogate time-to-event endpoints in clinical trials.
A two-stage model for evaluating both trial-level and patient-level surrogacy of correlated time-to-event endpoints has been introduced, using patient-level data when multiple clinical trials are available. However, the associated maximum likelihood approach often suffers from numerical problems when different baseline hazards among trials and imperfect estimation of treatment effects are assum...
متن کاملStatistical controversies in clinical research: assessing pathologic complete response as a trial-level surrogate end point for early-stage breast cancer.
BACKGROUND A trial-level surrogate end point for a randomized clinical trial may allow assessment of the relative benefits of the treatment to be performed at an earlier time point and potentially with a smaller sample size. However, determining whether an end point is a reliable trial-level surrogate based on results of previous trials is not straightforward. The question of trial-level surrog...
متن کاملSurrogacy assessment using principal stratification when surrogate and outcome measures are multivariate normal.
In clinical trials, a surrogate outcome variable (S) can be measured before the outcome of interest (T) and may provide early information regarding the treatment (Z) effect on T. Using the principal surrogacy framework introduced by Frangakis and Rubin (2002. Principal stratification in causal inference. Biometrics 58, 21-29), we consider an approach that has a causal interpretation and develop...
متن کاملMeta-analysis for surrogacy: accelerated failure time models and semicompeting risks modeling.
There has been great recent interest in the medical and statistical literature in the assessment and validation of surrogate endpoints as proxies for clinical endpoints in medical studies. More recently, authors have focused on using metaanalytical methods for quantification of surrogacy. In this article, we extend existing procedures for analysis based on the accelerated failure time model to ...
متن کاملEvaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16.
BACKGROUND The identification of surrogate endpoints that can replace true outcome endpoints is crucial to the rapid evaluation of new cancer drugs. Retrospective analyses of phase II and III trials in metastatic androgen-independent prostate cancer have shown associations between declines in serum prostate-specific antigen (PSA) levels and survival. We evaluated PSA changes as potential surrog...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Computational Statistics & Data Analysis
دوره 55 شماره
صفحات -
تاریخ انتشار 2011